Agyeman, Philipp; Desgrandchamps, Daniel; Vaudaux, Bernard; Berger, Christoph; Diana, Alessandro; Heininger, Ulrich; Siegrist, Claire-Anne; Aebi, Christoph (2009). Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories. Vaccine, 27(35), pp. 4771-5. Amsterdam: Elsevier 10.1016/j.vaccine.2009.05.097
Full text not available from this repository. (Request a copy)To evaluate primary care physicians' attitude towards implementation of rotavirus (RV) immunisation into the Swiss immunisation schedule, an eight-question internet-based questionnaire was sent to the 3799 subscribers of InfoVac, a nationwide web-based expert network on immunisation issues, which reaches >95% of paediatricians and smaller proportions of other primary care physicians. Five demographic variables were also inquired. Descriptive statistics and multivariate analyses for the main outcome "acceptance of routine RV immunisation" and other variables were performed. Diffusion of innovation theory was used for data assessment. Nine-hundred seventy-seven questionnaires were returned (26%). Fifty percent of participants were paediatricians. Routine RV immunisation was supported by 146 participants (15%; so called early adopters), dismissed by 620 (64%), leaving 211 (21%) undecided. However, when asked whether they would recommend RV vaccination to parents if it were officially recommended by the federal authorities and reimbursed, 467 (48.5%; so called early majority) agreed to recommend RV immunisation. Multivariate analysis revealed that physicians who would immunise their own child (OR: 5.1; 95% CI: 4.1-6.3), hospital-based physicians (OR: 1.6; 95% CI: 1.1-2.3) and physicians from the French (OR: 1.6; 95% CI: 1.2-2.3) and Italian speaking areas of Switzerland (OR: 2.5; 95% CI: 1.1-5.8) were more likely to support RV immunisation. Diffusion of innovation theory predicts a >80% implementation if approximately 50% of a given population support an innovation. Introduction of RV immunisation in Switzerland is likely to be successful, if (i) the federal authorities issue an official recommendation and (ii) costs are covered by basic health care insurance.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine |
UniBE Contributor: |
Agyeman, Philipp Kwame Abayie, Aebi, Christoph |
ISSN: |
0264-410X |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Anette van Dorland |
Date Deposited: |
04 Oct 2013 15:12 |
Last Modified: |
02 Mar 2023 23:23 |
Publisher DOI: |
10.1016/j.vaccine.2009.05.097 |
PubMed ID: |
19540950 |
Web of Science ID: |
000268827500008 |
URI: |
https://boris.unibe.ch/id/eprint/31795 (FactScience: 196476) |
Actions (login required)
 |
Edit item |